Comparison of 5 year treatment outcomes between alemtuzumab versus natalizumab fingolimod and interferon 1a

---

Kalincik T., Brown j., Robertson R., Willis m., Scolding N., Pearson O., ...More

ECTRIMS 2016, 13 - 16 September 2016, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Karadeniz Technical University Affiliated: Yes